← Back to Search

Financial Incentives for Smoking Cessation in Pregnancy

N/A

Waitlist Available

Research Sponsored by University of Oklahoma

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

are a female ≤ 25 weeks pregnant

are ≥ 18 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks postpartum

Awards & highlights

Study Summary

This trial is testing whether giving small financial incentives to pregnant women who want to quit smoking will help them actually quit.

Who is the study for?

This trial is for pregnant women under 25 weeks along, who smoke at least 5 cigarettes daily, are over 18 years old, speak English, and have Medicaid. They must be seeking smoking cessation treatment through the Oklahoma Tobacco Helpline and willing to enroll in a program involving multiple calls.Check my eligibility

What is being tested?

The study tests if small financial rewards can help pregnant women quit smoking. It compares standard care from the Oklahoma Tobacco Helpline with an added incentive program that gives escalating money rewards for attending coaching calls and proving they've stopped smoking.See study design

What are the potential side effects?

There are no direct medical side effects discussed since this trial involves financial incentives rather than medication or medical procedures. However, participants may experience stress or disappointment related to success or failure in quitting smoking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a woman and less than 25 weeks pregnant.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks postpartum

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks postpartum

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Biochemically verified abstinence 12 weeks post enrollment

Self-reported abstinence 12 weeks postpartum

Side effects data

From 2012 Phase 4 trial • 122 Patients • NCT01513330

Peristomal skin redness

Granulation in the peristomal area

Peristomal burns

Peristomal allergic contact dermatitis

Peristomal skin erosion

Diarrhoea

Pain in the peristomal area

Itching

100%

80%

60%

40%

20%

Study treatment Arm

SenSura Mio

Standard Care

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Standard Care + Financial IncentivesExperimental Treatment2 Interventions

Financial Incentives participants will receive standard care plus incentives for completing counseling calls and abstinence.

Group II: Standard CareActive Control1 Intervention

Participants randomized to Standard Care will be offered weekly counseling calls and pharmacotherapy.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Standard Care + Financial Incentives

2017

N/A

~490

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor

455 Previous Clinical Trials

97,510 Total Patients Enrolled

3 Trials studying Tobacco Use

189 Patients Enrolled for Tobacco Use

Media Library

Standard Care + Financial Incentives Clinical Trial Eligibility Overview. Trial Name: NCT05415371 — N/A

Tobacco Use Research Study Groups: Standard Care, Standard Care + Financial Incentives

Tobacco Use Clinical Trial 2023: Standard Care + Financial Incentives Highlights & Side Effects. Trial Name: NCT05415371 — N/A

Standard Care + Financial Incentives 2023 Treatment Timeline for Medical Study. Trial Name: NCT05415371 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is the ideal candidate for this medical experiment?

"Aspiring participants in this trial should be between 18 and 105 years of age, as well as have a specific socioeconomic status. The total number of enrollees sought is 100."

Answered by AI

Are there any available openings to join this research endeavor?

"As indicated by clinicaltrials.gov, this medical trial is no longer enrolling participants. Initially posted on November 1st 2022 and having its last update on October 31st 2022, the study has since closed off enrollment; however, there are 176 other trials that are taking in patients at present."

Answered by AI